Mechanisms of drug resistance in AML

Cancer Treat Res. 2002:112:237-62. doi: 10.1007/978-1-4615-1173-1_12.

Authors

Michael Andreeff¹, Marina Konopleva

Affiliation

¹ Section of Molecular Hematology and Therapy, Department of Blood and Marrow Transplantation, University of Texas MD Anderson Cancer Center, Houston, Texas, USA.

PMID: 12481719
DOI: 10.1007/978-1-4615-1173-1_12

No abstract available

Publication types

Review

MeSH terms

ATP Binding Cassette Transporter, Subfamily B, Member 1 / metabolism
Animals
Apoptosis
Cytokines / metabolism
Drug Resistance, Multiple
Drug Resistance, Neoplasm*
Humans
Leukemia, Myeloid, Acute / drug therapy*
Leukemia, Myeloid, Acute / pathology
Mice
Mice, SCID
Neovascularization, Pathologic
Phenotype
Stromal Cells / metabolism

Substances

ATP Binding Cassette Transporter, Subfamily B, Member 1
Cytokines